AESKU.BION - Infectious Disease Test Systems

AESKU.BION Infectious Disease IFA Test Systems are indirect fluorescent antibody assays for the qualitative and/or semi-quantitative determination of specific infectious disease antibodies in human serum. They are intended for use as an aid in the diagnosis of primary infection, reinfection or reactivation of the latent virus as well as a determination of immunological experience and/or immune status.

 

Instructions for use (ZIP file Download | 7.84 MB)

 

120 Test Kit
10 x 12-Well Antigen Substrate Slides, 1 x 0.5 mL Positive Control Serum, 1 x 0.5 mL Negative Control Serum, 2 x 3.5 mL Conjugate, 1 x 3.5 mL Mounting Medium, 2 x 1 liter packets PBS

 

 Code Number
 Product Name
Product Description
Size
CMG-120
Cytomegalovirus
lgG
The AESKU.BION CMV-G (Cytomegalovirus) ANTIBODY TEST SYSTEM is an indirect fluorescent antibody assay for the qualitative and/or semi-quantitative determination of CMV lgG antibodies in human serum. Intended for use as an aid in the diagnosis of primary infection, reinfection or reactivation of the latent virus, and also as a determination of immunological experience with CMV. This Test System is not intended for use by blood banks for blood donor screening.
120 Tests
EBG-120
Epstein Barr
Virus VCA, lgG
The AESKU.BION EBV-G (VCA) ANTIBODY TEST SYSTEM (Epstein-Barr Virus Viral Capsid Antigen) is an indirect fluorescent antibody assay for the qualitative and/or semi-quantitative determination of EBV-VCA lgG antibodies in human serum. Intended for use as an aid in the diagnosis of primary infection (Infectious Mononucleosis), re-infection or reactivation of the latent virus and as a determination of immunological experience with EBV.
120 Tests
EBM-120
Epstein Barr
Virus VCA, lgM
The AESKU.BION EBV-M (VCA) ANTIBODY TEST SYSTEM (Epstein-Barr Virus Viral Capsid Antigen) is an indirect fluorescent antibody assay for the qualitative and/or semi-quantitative determination of EBV-VCA lgM antibodies, in human serum. Intended for use as an aid in the diagnosis of primary infection (Infectious Mononucleosis), re-infection or reactivation of the latent virus, and also as a determination of immunological experience with EBV.
120 Tests
HS1G-120
Herpes
Simplex Virus
Type 1, lgG
The AESKU.BION HSV1-G (Herpes Simplex Virus type 1) ANTIBODY TEST SYSTEM is an indirect fluorescent antibody assay for the qualitative and/or semiquantitative determination of HSV lgG antibodies in human serum. Intended for use as an aid in the diagnosis of primary infection, re-infection or reactivation of the latent virus, and also as a determination of immunological experience with HSV.
120 Tests
HS2G-120
Herpes
Simplex Virus
Type 2, lgG
The AESKU.BION HSV2-G (Herpes Simplex Virus type 2 ) ANTIBODY TEST SYSTEM is an indirect fluorescent antibody assay for the qualitative and/or semi-quantitative determination of HSV lgG antibodies in human serum. Intended for use as an aid in the diagnosis of primary infection, re-infection or reactivation of the latent virus, and also as a determination of immunological experience with HSV.
120 Tests
MEG-120
Measles
(Rubeola)
Virus, IgG
The AESKU.BION MEASLES-G ANTIBODY TEST SYSTEM is an indirect fluorescent antibody assay for the qualitative and/or semi-quantitative determination of Measles (Rubeola) lgG antibodies in human serum. Intended for use as an aid in the diagnosis of primary infection and as a determination of immune status.
120 Tests
MEM-120
Measles
(Rubeola)
Virus, IgM
The AESKU.BION MEASLES-M ANTIBODY TEST SYSTEM is an indirect fluorescent antibody assay for the qualitative and/or semi-quantitative determination of Measles (Rubeola) lgM antibodies in human serum. Intended for use as an aid in the diagnosis of recent infection with Measles virus.
120 Tests
MUG-120
Mumps Virus,
lgG
The AESKU.BION MUMPS-G ANTIBODY TEST SYSTEM is an indirect fluorescent antibody assay for the qualitative and/or semi-quantitative determination of Mumps lgG antibodies in human serum. Intended for use as an aid in the diagnosis of primary infection and as a detemination of immune status.
120 Tests